news & events




February 2019

AROMICS launches BERMES project, with the financing support of Horizon 2020 SME instrument phase 2 program

The European Commission has allocated, through the H2020-EIC-SMEInst-2018-2020-Phase 2 program,  a total of 1,085.659€ to the BERMES project of Aromics, the objective of which is to complete the regulatory pre-clinical stage in order to begin studies in humans of the drug NAX035 for malignant...


January 2019

AMMIC platform works on developing novel drugs for rare diseases

AROMICS is one of the participants on the project AMMIC: an accelerator platform for the development of new therapies in minoritary disease in Catalonia. The project is partially supported by the Operative Program FEDER in Catalonia 2014-2020. AMMIC...


December 2018

AROMICS wishes you Season's Greetings

AROMICS wishes all of you Merry Christmas and happy New 2019!


November 2018

AROMICS will participate at ETOP meeting

Our CEO Dr. Plasencia will participate at the 7th ETOP Residential Workshop and the ETOP Annual Meeting 2018 that will take...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9